UK Markets open in 1 hr 19 mins

Coloplast A/S (COLO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
854.00+9.00 (+1.07%)
At close: 04:59PM CET

Coloplast A/S

Holtedam 1-3
Humlebæk 3050
45 49 11 11 11

IndustryMedical Instruments & Supplies
Full-time employees14,000

Key executives

NameTitlePayExercisedYear born
Mr. Kristian VillumsenPres & CEO16.1MN/A1970
Mr. Anders Lonning-SkovgaardExec. VP & CFO8MN/A1972
Mr. Allan RasmussenExec. VP of Global Operations7.3MN/A1967
Mr. Nicolai Buhl AndersenExec. VP of Innovation6.6MN/A1969
Mr. Paul MarcunExec. VP of Growth8.3MN/A1967
Mr. Rasmus Hannemann MøllerSr. VP of Wound & Skin CareN/AN/AN/A
Mr. Thomas BarfodSr. Controller & Employees Representative Director450kN/A1970
Ellen BjurgertVP of Investor RelationsN/AN/AN/A
Dennis KaysenDirector of Corp. CommunicationsN/AN/AN/A
Dorthe RonnauSr. VP of People & CultureN/AN/A1966
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in DKK.


Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Corporate governance

Coloplast A/S’s ISS governance QualityScore as of 1 October 2022 is 4. The pillar scores are Audit: 1; Board: 5; Shareholder rights: 9; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.